Ventyx Biosciences, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q3 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Ventyx Biosciences, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q3 2020 to Q2 2024.
  • Ventyx Biosciences, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $5.77M, a 26.7% decline year-over-year.
  • Ventyx Biosciences, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $26.5M, a 13% increase year-over-year.
  • Ventyx Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $28.6M, a 72.5% increase from 2022.
  • Ventyx Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $16.6M, a 507% increase from 2021.
  • Ventyx Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $2.73M, a 5967% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $26.5M $5.77M -$2.1M -26.7% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $28.6M $6.54M -$24K -0.37% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $28.6M $6.15M +$1.32M +27.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-27
Q3 2023 $27.3M $8.01M +$3.84M +92.2% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $23.4M $7.87M +$3.74M +90.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $19.7M $6.57M +$3.12M +90.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $16.6M $4.83M +$3.44M +247% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-27
Q3 2022 $13.1M $4.17M +$3.2M +330% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $9.94M $4.13M +$3.84M +1334% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $6.09M $3.44M +$3.36M +4205% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $2.73M $1.39M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-23
Q3 2021 $969K +$955K +6821% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-04
Q2 2021 $288K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $80K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q3 2020 $14K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.